Adam Bazih and Troy Norris will discuss how to estimate development timelines and investments, production and customer acquisition costs, to forecast profit and loss for the business. Based on this, we can estimate cash flow requirements and begin to value the business under alternative scenarios. A key focus will be on the role of risk, and smart risk-taking, for driving shareholder value and value step-ups.
Speaker Names: Adam Bazih (Director, Healthcare and Life Sciences at the Harvard Innovation Labs) and Troy Norris
Adam Bazih is the Director, Healthcare and Life Sciences at the Harvard Innovation Labs. Adam has over fifteen years of entrepreneurial, angel, and venture capital experience. Adam founded and co-founded over five startups, two of which led to successful exits. Additionally, Adam has advised and helped multiple companies, from startups to Fortune 500 with corporate and product strategy. Adam’s work is featured in multiple business and technical journals.
Adam holds an MBA from the University of Chicago Booth School of Business, studied medicine at OUHSC/UCLA, and microbiology and chemistry as an undergraduate at the University of Oklahoma Honors College.
Troy Norris focuses on innovation strategy, transactions and new product commercialization to drive growth and value for life sciences companies and their investors. As global leader of Locust Walk’s Strategy and Analytics practice, Troy advises clients on portfolio and partnering strategy. As Managing Director of Valamont Advisors, Troy acts as an independent business strategy advisor. Having held senior positions in the life sciences practices of leading strategy consulting firms such as McKinsey, L.E.K. and EY-Parthenon, Troy has advised each of the top pharmaceutical and biotech companies, and more than 125 other therapeutic, diagnostic, medical device and digital health innovators.
Troy was previously Vice President of Corporate Development for Biogen Idec, and earlier led Biogen’s R&D investment prioritization process. Troy also led Business Development for three new ventures. He began his career with Astra USA where he led Clinical Operations, Finance and Planning. Troy received a BA in biochemistry from Harvard College and an MBA from Harvard Business School. Troy serves as an Innovation Fellow with Harvard Innovation Labs, as a member of MassBio’s Academic Initiatives Steering Committee, and a mentor to entrepreneur founders via HiLabs and MassConnect.
This session is for team members participating in the i-lab’s Venture Program. Registration is available via the i-lab portal (click below) or through the program calendar. If you are a Harvard affiliate who would like to join this session or if you don’t have access to the i-lab portal, please email email@example.com.
Register here: https://my.innovationlabs.harvard.edu